Top Markets
Coin of the day
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
株式のランク #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
株価
$4.51
時価総額
$540.82M
変化(1日)
-2.42%
変化(1年)
-43.50%
CN
取引 Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

カテゴリー

Nanjing Hicin Pharmaceutical Co., Ltd.(300584)の収益
Aug 2026 時点の収益 TTM: 0
Nanjing Hicin Pharmaceutical Co., Ltd. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Nanjing Hicin Pharmaceutical Co., Ltd. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。